These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26941026)

  • 21. Acetazolamide efficacy in hypokalemic periodic paralysis and the predictive role of genotype.
    Matthews E; Portaro S; Ke Q; Sud R; Haworth A; Davis MB; Griggs RC; Hanna MG
    Neurology; 2011 Nov; 77(22):1960-4. PubMed ID: 22094484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of hypokalemic periodic paralysis with topiramate.
    Fiore DM; Strober JB
    Muscle Nerve; 2011 Jan; 43(1):127-9. PubMed ID: 21171065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Refractory familial hypokalaemic periodic paralysis leading to cardiovascular compromise.
    Awuah DO; Hussain MS; Ponnapalli A; Deliwala SS; Seedahmed EM; Bachuwa G
    BMJ Case Rep; 2022 Feb; 15(2):. PubMed ID: 35131788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The value of the association of a carbonic anhydrase inhibitor with a potassium salt. (Studies of the behavior of plasmatic and urinary K+)].
    Verdi GP; De Molfetta V; Maccari M; Bozzini S
    Minerva Oftalmol; 1967; 9(3):103-7. PubMed ID: 5604130
    [No Abstract]   [Full Text] [Related]  

  • 25. Aetiological, clinical and metabolic profile of hypokalaemic periodic paralysis in adults: a single-centre experience.
    Rao N; John M; Thomas N; Rajaratnam S; Seshadri MS
    Natl Med J India; 2006; 19(5):246-9. PubMed ID: 17203677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The primary periodic paralyses: diagnosis, pathogenesis and treatment.
    Venance SL; Cannon SC; Fialho D; Fontaine B; Hanna MG; Ptacek LJ; Tristani-Firouzi M; Tawil R; Griggs RC;
    Brain; 2006 Jan; 129(Pt 1):8-17. PubMed ID: 16195244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapy of paroxysmal hypokalemic paralysis: experience with diclofenamid].
    Sander C
    Monatsschr Kinderheilkd; 1988 Mar; 136(3):149-50. PubMed ID: 3374500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Favorable results of the treatment of the hyperkalemic form of periodic paralysis with salbutamol].
    Rysz A; Emeryk B
    Neurol Neurochir Pol; 1985; 19(5):444-7. PubMed ID: 2421192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of hypokalemic periodic paralysis with topiramate.
    García-Sobrino T; Pardo J
    Eur J Neurol; 2014 Sep; 21(9):e73-4. PubMed ID: 25065459
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effects of carbonic anhydrase inhibition on respiratory function in patients with chronic respiratory insufficiency. During rest].
    Chiesa AG; Ciappi G; Balbi L; Dolcetti A
    Minerva Med; 1966 Oct; 57(86):3542-8. PubMed ID: 4958931
    [No Abstract]   [Full Text] [Related]  

  • 31. [Ocular hypotonic effect of hematic acidifying agents: carbonic anhydrase inhibitors].
    Virno M; Pecori-Giraldi J; Pivetti-Pezzi P; Leonardi E
    Boll Ocul; 1970 Sep; 49(9):469-91. PubMed ID: 5522152
    [No Abstract]   [Full Text] [Related]  

  • 32. [A case of hypokalemic periodic paralysis: utility of exercise test for the assessment of therapeutic efficacy].
    Watanabe M; Hasegawa T; Takeda A; Shiga Y; Itoyama Y
    No To Shinkei; 2003 Jun; 55(6):527-9. PubMed ID: 12884806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A summary review of the diagnosis and pathology of the primary familial periodic paralyses.
    Meyers KR
    Ann Clin Lab Sci; 1975; 5(3):216-21. PubMed ID: 1094905
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effects of the inhibition of carbonic anhydrase on respiratory function in patients with chronic respiratory insufficiency. During muscular exercise of varying intensity].
    Chiesa AG; Ciappi G; Balbi L; Dolcetti A
    Minerva Med; 1966 Oct; 57(86):3548-52. PubMed ID: 5927225
    [No Abstract]   [Full Text] [Related]  

  • 35. [Diclofenamide].
    Boeve M; Bult W
    Tijdschr Diergeneeskd; 2005 Apr; 130(8):256. PubMed ID: 15871395
    [No Abstract]   [Full Text] [Related]  

  • 36. Letter: Salbutamol in hyperkalaemic familial periodic paralysis.
    Harris DM
    Lancet; 1976 Feb; 1(7956):427. PubMed ID: 55692
    [No Abstract]   [Full Text] [Related]  

  • 37. [Periodic paralysis: new pathophysiological aspects].
    Fontaine B
    Bull Acad Natl Med; 2008 Nov; 192(8):1543-8; discussion 1549-50. PubMed ID: 19445371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of the inhibition of carbonic anhydrase on respiratory function in patients with chronic respiratory insufficiency. Tissue oxygenation and oxygen debt during muscular exercise of varying intensity].
    Chiesa AG; Colongo Oliaro PG; Ciappi G; Ramello A; Balbi L; Dolcetti A; Motta PE
    Minerva Med; 1966 Oct; 57(86):3552-5. PubMed ID: 5924867
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis.
    Wagg A; Wyndaele JJ; Sieber P
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):14-24. PubMed ID: 16730617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug repurposing in skeletal muscle ion channelopathies.
    Altamura C; Saltarella I; Campanale C; Laghetti P; Desaphy JF
    Curr Opin Pharmacol; 2023 Feb; 68():102329. PubMed ID: 36512979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.